i-Seq Biotechnology

Business Services · Alabama, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

775 N University Blvd Ste 150, Mobile, A...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About i-Seq Biotechnology

i-Seq Biotechnology, Inc. specializes in the development of novel, broad-spectrum vaccines and therapeutics targeted at infectious disease pathogens affecting human health globally. Established in 2024, the company addresses the limitations of currently available vaccines and the challenges posed by antibiotic resistance. Utilizing CRISPR interference screening technology (CRISPRi-Seq), their team identifies new vaccine antigens and therapeutic targets. Their intended clients are stakeholders in global health, looking to improve infection prevention and treatment options.Explore more
i-Seq Biotechnology's Social MediaPopular Searchesi-Seq Biotechnology IncSIC Code 87,873NAICS Code 54,541Show more

Is i-Seq Biotechnology your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

i-Seq Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

i-Seq Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about i-Seq Biotechnology.

i-Seq Biotechnology Tech Stack

A closer look at the technologies used by i-Seq Biotechnology

Top Business Services Companies

Frequently Asked Questions Regarding i-Seq Biotechnology

What is i-Seq Biotechnology's official website?
i-Seq Biotechnology's official website is www.i-seq.com
What is i-Seq Biotechnology's Revenue?
i-Seq Biotechnology's revenue is <$5 Million
What is i-Seq Biotechnology's SIC code?
i-Seq Biotechnology's SIC: 87,873
What is i-Seq Biotechnology's NAICS code?
i-Seq Biotechnology's NAICS: 54,541
How many employees does i-Seq Biotechnology have?
i-Seq Biotechnology has 11-50 employees
What industry does i-Seq Biotechnology belong to?
i-Seq Biotechnology is in the industry of: Business Services, Research & Development
What technology does i-Seq Biotechnology use?
Some of the popular technologies that i-Seq Biotechnology uses are: WordPress.org, PHP, iubenda, Font Awesome
What does i-Seq Biotechnology do?

i-Seq Biotechnology, Inc. specializes in the development of novel, broad-spectrum vaccines and therapeutics targeted at infectious disease pathogens affecting human health globally. Established in 2024, the company addresses the limitations of currently available vaccines and the challenges posed by antibiotic resistance. Utilizing CRISPR interfere... nce screening technology (CRISPRi-Seq), their team identifies new vaccine antigens and therapeutic targets. Their intended clients are stakeholders in global health, looking to improve infection prevention and treatment options.Read More

What are i-Seq Biotechnology social media links?
i-Seq Biotechnology Linkedin page
Is i-Seq Biotechnology a public company?
i-Seq Biotechnology is private company therefore does not currently have an official ticker symbol
See more information about i-Seq Biotechnology

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.